Association of Cardiometabolic Factors and Insulin Resistance Surrogates with Mortality in Participants from the Korean Genome and Epidemiology Study

Overview

Journal Lipids Health Dis

Publisher Biomed Central

Specialties Biochemistry
Endocrinology

Date 2023 Dec 2

PMID 38041195

Authors

Anthony Kityo

Sang-Ah Lee

Affiliations

Soon will be listed here.

Abstract

Background: Simple biochemical and anthropometric measurements such as fasting blood glucose (FBG), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), waist circumference (WC), and body mass index (BMI) are used to formulate insulin resistance (IR) indices. Whether these indices provide new predictive information for mortality remains unknown. This study examined the relationships of biochemical, anthropometric, and IR indices with mortality risk, as well as their predictive performance.

Methods: The data source was the Korean Genome and Epidemiology Study (2004-2020) involving 114,957 participants whose data were linked to death records. The IR indices- triglyceride-glucose index (TyG), TyG-BMI, TyG-WC, visceral adiposity index (VAI), lipid accumulation product (LAP), and metabolic score for insulin resistance (METS-IR) were computed using standard formulae. The associations were examined using restricted cubic splines. The predictive performance was compared using the log-likelihood ratio chi-square test.

Results: Body mass index was U-shaped, HDL-C was reverse J-shaped, and FBG and TG levels were J-shaped associated with all-cause mortality. Results showed U-shaped (TyG), J-shaped (TyG-BMI, VAI, LAP, and METS-IR), and reverse J-shaped (TyG-WC) associations with all-cause mortality. The percentages of new predictive information for all-cause mortality explained by the FBG level, BMI, TyG-BMI, and METIR were 3.34%, 2.33%, 1.47%, and 1.37%, respectively. Other IR indices and biochemical and anthropometric measurements provided < 1.0% of new predictive information. For cardiovascular disease mortality, the FBG, BMI, METIR, TyG-BMI, and HDL-C levels explained 2.57%, 2.12%, 1.59%, 1.30%, and 1.27% of new predictive information respectively. Moreover, the risks of cancer mortality explained by FBG level, VAI, and HDL-C level were 2.05%, 1.49%, and 1.28%, respectively.

Conclusions: Fasting blood glucose level is a superior predictor of mortality risk and may be used as a simple predictive and preventative factor.

Citing Articles

The association between TyG index and cardiovascular mortality is modified by antidiabetic or lipid-lowering agent: a prospective cohort study.

Fang C, Peng N, Cheng J, Zhang X, Gu W, Zhu Z Cardiovasc Diabetol. 2025; 24(1):65.

PMID: 39920712 PMC: 11806668. DOI: 10.1186/s12933-025-02620-z.

Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015).

Chen Y, Zhong Z, Gue Y, Banach M, McDowell G, Mikhailidis D Lancet Reg Health Eur. 2025; 49:101182.

PMID: 39759579 PMC: 11697418. DOI: 10.1016/j.lanepe.2024.101182.

The association between the metabolic score for insulin resistance and mortality in patients with cardiovascular disease: a national cohort study.

Su X, Rao H, Zhao C, Zhang X, Li D Front Endocrinol (Lausanne). 2025; 15:1479980.

PMID: 39758345 PMC: 11695433. DOI: 10.3389/fendo.2024.1479980.

Association of the atherogenic index of plasma and modified triglyceride-glucose indices with digestive diseases among middle-aged and older population in China.

Gao T, Ren M, Feng Y, Li Y, Zhang X, He S Lipids Health Dis. 2024; 23(1):398.

PMID: 39616367 PMC: 11607860. DOI: 10.1186/s12944-024-02321-8.

Lipid Accumulation Product Is Predictive of Cardiovascular Hospitalizations among Patients with Stable Ischemic Heart Disease: Long-Term Follow-Up of the LAERTES Study.

Papathanasiou K, Roussos C, Armylagos S, Rallidis S, Rallidis L J Cardiovasc Dev Dis. 2024; 11(10).

PMID: 39452286 PMC: 11508490. DOI: 10.3390/jcdd11100316.

References

Muhammad I, Bao X, Nilsson P, Zaigham S . Triglyceride-glucose (TyG) index is a predictor of arterial stiffness, incidence of diabetes, cardiovascular disease, and all-cause and cardiovascular mortality: A longitudinal two-cohort analysis. Front Cardiovasc Med. 2023; 9:1035105. PMC: 9846351. DOI: 10.3389/fcvm.2022.1035105. View

Jackson S, van Jaarsveld C, Beeken R, Gunter M, Steptoe A, Wardle J . Four-year stability of anthropometric and cardio-metabolic parameters in a prospective cohort of older adults. Biomark Med. 2015; 9(2):109-22. DOI: 10.2217/bmm.14.78. View

Wondmkun Y . Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications. Diabetes Metab Syndr Obes. 2020; 13:3611-3616. PMC: 7553667. DOI: 10.2147/DMSO.S275898. View

Lim J, Kim J, Koo S, Kwon G . Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007-2010 Korean National Health and Nutrition Examination Survey. PLoS One. 2019; 14(3):e0212963. PMC: 6405083. DOI: 10.1371/journal.pone.0212963. View

Ahn C, Hwang Y, Park S . Predictors of all-cause mortality among 514,866 participants from the Korean National Health Screening Cohort. PLoS One. 2017; 12(9):e0185458. PMC: 5619780. DOI: 10.1371/journal.pone.0185458. View

Bozorgmanesh M, Hadaegh F, Azizi F . Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis. 2010; 9:100. PMC: 2949857. DOI: 10.1186/1476-511X-9-100. View

Health Examinees Study Group . The Health Examinees (HEXA) study: rationale, study design and baseline characteristics. Asian Pac J Cancer Prev. 2015; 16(4):1591-7. DOI: 10.7314/apjcp.2015.16.4.1591. View

Zhou D, Liu X, Kenneth L, Huang Y, Feng Y . A Non-Linear Association of Triglyceride Glycemic Index With Cardiovascular and All-Cause Mortality Among Patients With Hypertension. Front Cardiovasc Med. 2022; 8:778038. PMC: 8828937. DOI: 10.3389/fcvm.2021.778038. View

Desquilbet L, Mariotti F . Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010; 29(9):1037-57. DOI: 10.1002/sim.3841. View

10.

DeFronzo R, Tobin J, Andres R . Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979; 237(3):E214-23. DOI: 10.1152/ajpendo.1979.237.3.E214. View

11.

Diamanti-Kandarakis E, Dunaif A . Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012; 33(6):981-1030. PMC: 5393155. DOI: 10.1210/er.2011-1034. View

12.

Er L, Wu S, Chou H, Hsu L, Teng M, Sun Y . Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals. PLoS One. 2016; 11(3):e0149731. PMC: 4773118. DOI: 10.1371/journal.pone.0149731. View

13.

Barzilai N, Ferrucci L . Insulin resistance and aging: a cause or a protective response?. J Gerontol A Biol Sci Med Sci. 2012; 67(12):1329-31. DOI: 10.1093/gerona/gls145. View

14.

Fiorentino T, Marini M, Succurro E, Andreozzi F, Sesti G . Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage. BMJ Open Diabetes Res Care. 2019; 7(1):e000911. PMC: 6861112. DOI: 10.1136/bmjdrc-2019-000911. View

15.

Ioachimescu A, Brennan D, Hoar B, Hoogwerf B . The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity (Silver Spring). 2009; 18(9):1836-44. DOI: 10.1038/oby.2009.453. View

16.

Kahn H, Valdez R . Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. Am J Clin Nutr. 2003; 78(5):928-34. DOI: 10.1093/ajcn/78.5.928. View

17.

Kim K, Lee Y, Lee I, Kim D, Jacobs Jr D, Lee D . Paradoxical Associations of Insulin Resistance With Total and Cardiovascular Mortality in Humans. J Gerontol A Biol Sci Med Sci. 2014; 70(7):847-53. DOI: 10.1093/gerona/glu194. View

18.

Simental-Mendia L, Rodriguez-Moran M, Guerrero-Romero F . The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008; 6(4):299-304. DOI: 10.1089/met.2008.0034. View

19.

Liu X, He G, Lo K, Huang Y, Feng Y . The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-linear Associated With All-Cause and Cardiovascular Mortality in the General Population. Front Cardiovasc Med. 2021; 7:628109. PMC: 7840600. DOI: 10.3389/fcvm.2020.628109. View

20.

Kim Y, Han B . Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium. Int J Epidemiol. 2016; 46(2):e20. PMC: 5837648. DOI: 10.1093/ije/dyv316. View